ID   T409
AC   CVCL_1Q88
SY   T-409
DR   BioSample; SAMN03151991
DR   Cosmic; 1530764
DR   Wikidata; Q54971556
RX   PubMed=18234965;
RX   PubMed=21868764;
CC   Problematic cell line: Contaminated. Shown to be a UM-SCC-1 derivative (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00427.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D5S818: 10,13
ST   D7S820: 9,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7707 ! UM-SCC-1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 17
RX   PubMed=18234965; DOI=10.1158/1541-7786.MCR-07-0221;
RA   Shareef M.M., Brown B., Shajahan S., Sathishkumar S., Arnold S.M.,
RA   Mohiuddin M., Ahmed M.M., Spring P.M.;
RT   "Lack of P-glycoprotein expression by low-dose fractionated radiation
RT   results from loss of nuclear factor-kappaB and NF-Y activation in oral
RT   carcinoma cells.";
RL   Mol. Cancer Res. 6:89-98(2008).
RX   PubMed=21868764; DOI=10.1158/1078-0432.CCR-11-0690;
RA   Zhao M., Sano D., Pickering C.R., Jasser S.A., Henderson Y.C.,
RA   Clayman G.L., Sturgis E.M., Ow T.J., Lotan R., Carey T.E., Sacks P.G.,
RA   Grandis J.R., Sidransky D., Heldin N.-E., Myers J.N.;
RT   "Assembly and initial characterization of a panel of 85 genomically
RT   validated cell lines from diverse head and neck tumor sites.";
RL   Clin. Cancer Res. 17:7248-7264(2011).